ERIS Lifescience
₹1,150
- Market Cap
- ₹15,797Cr.
- P/E Ratio
- 24.1
- P/B Ratio
- 4.08
- EPS (TTM)
- ₹47.72
- Div Yield
- 0.63%
- ROCE
- 14.1%
- ROE
- 18.7%
52W Low: ₹1,13152W High: ₹1,740
Themes:💊 Pharma & CDMO
Appears in 2 screens
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 23.0% a year over three years.
- Debt is 0.60× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
ERIS_Lifescience — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 24.1P/E: 24.1 | P/B: 4.08Growth
GrowingSales CAGR — 3Y: 23% · 1Y: 10%Profitability
ModerateROCE: 14.1% | ROE: 18.7%Key Metrics
Valuation
PEG Ratio 1.27
Price / Sales 4.89x
Price / FCF 65.5x
Book Value ₹282
Margins & returns
Operating Margin 35%